메뉴 건너뛰기




Volumn 13, Issue 6, 2002, Pages 557-566

Selective cytotoxicity of gemcitabine in bladder cancer cell lines

Author keywords

Gemcitabine; Intravesical chemotherapy; Spheroids; Transitional cell carcinoma

Indexed keywords

ANTIBODY; CYTOKERATIN 13 ANTIBODY; GEMCITABINE; UNCLASSIFIED DRUG; VIMENTIN ANTIBODY; ANTINEOPLASTIC ANTIMETABOLITE; COLORING AGENT; DEOXYCYTIDINE; DRUG DERIVATIVE; TETRAZOLIUM; THIAZOLE DERIVATIVE; THIAZOLYL BLUE;

EID: 0036021014     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001813-200207000-00002     Document Type: Article
Times cited : (38)

References (18)
  • 8
    • 0032858246 scopus 로고    scopus 로고
    • Gemcitabine plus cisplatin, an active regimen in advanced urothelial cancer: A phase II trial of the National Cancer Institute of Canada Clinical Trials Group
    • (1999) J Clin Oncol , vol.17 , pp. 2876-2881
    • Moore, M.J.1    Winquist, E.W.2    Murray, N.3
  • 16
    • 0021061819 scopus 로고
    • Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays
    • (1983) J Immunol Methods , vol.65 , pp. 55-63
    • Mosmann, T.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.